The Europe radiology information system (RIS) market is projected to reach from US$ 315.32 million in 2019 to US$ 574.44 million by 2027. This represents a CAGR of 8.0% from 2020 to 2027.
The growth of the Europe Radiology Information System (RIS)market is primarily attributed to advancements in diagnostic imaging solutions coupled with rising number of diagnostic procedures as well as increasing partnerships and collaborations.

The increasing active participation and approvals by regulatory agencies. FDA approvals are increasingly offering advancements in the RIS market. For instance, in 2019, Philips introduced IntelliSpace Cardiovascular 4.1, a cardiovascular image and information management system that offers efficient pediatric reporting capabilities. The launch of innovative software can enable better treatment and diagnosis owing to the rising prevalence of cardiovascular disorders among the population. Therefore, the growing number of diagnostic imaging procedures and advancements are likely to drive the growth of the global radiology information system market.

In terms of product, the integrated RIS segment held a considerable share of the for Europe Radiology Information System (RIS)market in 2019. This segment is also predicted to dominate the market by2027 owing to a higher demand. However, the services segment is anticipated to witness growth at a significant rate during the forecast period.

Instrument, US Food and Drug Administration, MHRA, and European Commission are among the major primary and secondary sources for the Europe Radiology Information System (RIS) market included in the report.